Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: A California Cancer Consortium trial

George Somlo, Ashkan Lashkari, William Bellamy, Todd M. Zimmerman, Joseph Tuscano, Margaret R. O'Donnell, Ann F. Mohrbacher, Stephen J. Forman, Paul Frankel, Helen X. Chen, James H. Doroshow, David R Gandara

Research output: Contribution to journalArticlepeer-review

37 Scopus citations
Original languageEnglish (US)
Pages (from-to)533-535
Number of pages3
JournalBritish Journal of Haematology
Issue number4
StatePublished - Aug 2011


  • Angiogenesis
  • Bevacizumab
  • Multiple myeloma
  • Thalidomide
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Hematology

Cite this